During the past decade, Kasukabe Chuo General Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 3 clinical trials were completed, i.e. on average, 60% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Kasukabe Chuo General Hospital" #1 sponsor was "Boston Scientific Corporation" with 3 trials, followed by "Society for Advancement of Coronary Intervention Research" with 2 trials sponsored, "C. R. Bard" with 1 trials sponsored, "Ferring Pharmaceuticals" with 1 trials sponsored and "Juntendo University" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kasukabe Chuo General Hospital" #1 collaborator was "Boehringer Ingelheim" with 1 trials as a collaborator and "Medicon, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Kasukabe Chuo General Hospital" are "Peripheral Arterial Disease" (3 trials), "Acute Heart Failure" (1 trials), "Arterial Occlusive Disease" (1 trials), "Artery Diseases, Peripheral" (1 trials) and "Atherosclerosis" (1 trials). Many other conditions were trialed in "Kasukabe Chuo General Hospital" in a lesser frequency.

Most popular intervention types in "Kasukabe Chuo General Hospital" are "Device" (8 trials), "Drug" (3 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Jetstream Atherectomy System" (2 trials), "Placebo" (2 trials), "Atherectomy Catheter" (1 trials), "Desmopressin" (1 trials) and "Empagliflozin 10 MG" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kasukabe Chuo General Hospital" are 10 trials for "All" genders.

Currently, there are NaN active trials in "Kasukabe Chuo General Hospital". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Kasukabe Chuo General Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Kasukabe Chuo General Hospital, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 5 trials that are defined as “Not Applicable".